Industry Research Reports
Home > Reports > Service & Software > Global and United States Virtual Screening for Drug Discovery Market Report & Forecast 2024-2030
Global and United States Virtual Screening for Drug Discovery Market Report & Forecast 2024-2030
Industry: Service & Software
Published Date: 2024-04-28
Pages: 121 Pages
Report ld: 3126035
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Virtual screening (VS) is a computational technique used in drug discovery to search libraries of small molecules in order to identify those structures which are most likely to bind to a drug target, typically a protein receptor or enzyme.
The global Virtual Screening for Drug Discovery revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
In United States the Virtual Screening for Drug Discovery revenue is expected to grow from US$ million in 2023 to US$ million by 2030, at a CAGR of % during the forecast period (2024-2030).
This report focuses on global and United States Virtual Screening for Drug Discovery market, also covers the segmentation data of other regions in regional level and county level.
The global key players of Virtual Screening for Drug Discovery include MedChemExpress, TargetMol, OpenEye Scientific, Eurofins Discovery, Sygnature Discovery, Jubilant Biosys, Schrödinger, Inc., Cresset Group, ComputaBio, Profacgen, etc. The global five biggest players hold a share of % in 2023.
Global Virtual Screening for Drug Discovery Scope and Market Size
Virtual Screening for Drug Discovery market is segmented in regional and country level, by players, by Type, and by Application. Players, stakeholders, and other participants in the global Virtual Screening for Drug Discovery market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2019-2030.
For United States market, this report focuses on the Virtual Screening for Drug Discovery market size by players, by Type, and by Application, for the period 2019-2030. The key players include the global and local players which play important roles in United States.
MARKET SEGMENTATION
By Company
- MedChemExpress
- TargetMol
- OpenEye Scientific
- Eurofins Discovery
- Sygnature Discovery
- Jubilant Biosys
- Schrödinger, Inc.
- Cresset Group
- ComputaBio
- Profacgen
- CD ComputaBio
- Creative Biolabs
- BOC Sciences
- CKTTDB
- HitGen
- WuXi AppTec
- LeadBuilder
- CSNpharm
- ChemNavigator
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Structure-based Virtual Screening (SBVS)
- Ligand-based Virtual Screening (LBVS)
- Hybrid Methods
Segment by Application
- Pharmaceutical Company
- Universities and Research Institutions
- Others
CHAPTER OUTLINE
Chapter 1: Introduces Virtual Screening for Drug Discovery definition, global market size, United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Detailed analysis of Virtual Screening for Drug Discovery companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Revenue of Virtual Screening for Drug Discovery in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6: Americas by Type, by Application and by country, revenue for each segment.
Chapter 7: EMEA by Type, by Application and by region, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: APAC (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Virtual Screening for Drug Discovery revenue, gross margin, and recent development, etc.
Chapter 11: Analyst's Viewpoints/Conclusion
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Virtual Screening for Drug Discovery Product Introduction
1.2 Global Virtual Screening for Drug Discovery Outlook, 2019 VS 2023 VS 2030
1.2.1 Global Virtual Screening for Drug Discovery Market Size for the Year 2019-2030
1.2.2 United States Virtual Screening for Drug Discovery Market Size for the Year 2019-2030
1.3 Virtual Screening for Drug Discovery Market Size, United States VS Global, 2019 VS 2023 VS 2030
1.3.1 The Market Share of United States Virtual Screening for Drug Discovery in Global, 2019 VS 2023 VS 2030
1.3.2 The Growth Rate of Virtual Screening for Drug Discovery Market Size, United States VS Global, 2019 VS 2023 VS 2030
1.4 Virtual Screening for Drug Discovery Market Dynamics
1.4.1 Virtual Screening for Drug Discovery Industry Trends
1.4.2 Virtual Screening for Drug Discovery Market Drivers
1.4.3 Virtual Screening for Drug Discovery Market Challenges
1.4.4 Virtual Screening for Drug Discovery Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Virtual Screening for Drug Discovery by Type
2.1 Virtual Screening for Drug Discovery Market by Type
2.1.1 Structure-based Virtual Screening (SBVS)
2.1.2 Ligand-based Virtual Screening (LBVS)
2.1.3 Hybrid Methods
2.2 Global Virtual Screening for Drug Discovery Market Size by Type (2019, 2023 & 2030)
2.3 Global Virtual Screening for Drug Discovery Market Size by Type (2019-2030)
2.4 United States Virtual Screening for Drug Discovery Market Size by Type (2019, 2023 & 2030)
2.5 United States Virtual Screening for Drug Discovery Market Size by Type (2019-2030)
3 Virtual Screening for Drug Discovery by Application
3.1 Virtual Screening for Drug Discovery Market by Application
3.1.1 Pharmaceutical Company
3.1.2 Universities and Research Institutions
3.1.3 Others
3.2 Global Virtual Screening for Drug Discovery Market Size, by Application (2019, 2023 & 2030)
3.3 Global Virtual Screening for Drug Discovery Market Size by Application (2019-2030)
3.4 United States Virtual Screening for Drug Discovery Market Size by Application (2019, 2023 & 2030)
3.5 United States Virtual Screening for Drug Discovery Market Size by Application (2019-2030)
4 Global Virtual Screening for Drug Discovery Competitor Landscape by Company
4.1 Global Virtual Screening for Drug Discovery Market Size by Company
4.1.1 Global Key Companies of Virtual Screening for Drug Discovery, Ranked by Revenue (2023)
4.1.2 Global Virtual Screening for Drug Discovery Revenue by Player (2019-2024)
4.2 Global Virtual Screening for Drug Discovery Concentration Ratio (CR)
4.2.1 Virtual Screening for Drug Discovery Market Concentration Ratio (CR) (2019-2024)
4.2.2 Global Top 5 and Top 10 Largest Companies of Virtual Screening for Drug Discovery in 2023
4.2.3 Global Virtual Screening for Drug Discovery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of Virtual Screening for Drug Discovery Head office and Area Served
4.4 Global Key Players of Virtual Screening for Drug Discovery, Product and Application
4.5 Global Key Players of Virtual Screening for Drug Discovery, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 United States Virtual Screening for Drug Discovery Market Size by Company
4.7.1 Key Players of Virtual Screening for Drug Discovery in United States, Ranked by Revenue (2023)
4.7.2 United States Virtual Screening for Drug Discovery Revenue by Players (2022, 2023 & 2024)
5 Global Virtual Screening for Drug Discovery Market Size by Region
5.1 Global Virtual Screening for Drug Discovery Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Virtual Screening for Drug Discovery Market Size by Region (2019-2030)
5.2.1 Global Virtual Screening for Drug Discovery Market Size by Region: 2019-2024
5.2.2 Global Virtual Screening for Drug Discovery Market Size by Region: 2025-2030
6 Americas
6.1 Americas Virtual Screening for Drug Discovery Market Size YoY Growth 2019-2030
6.2 Americas Virtual Screening for Drug Discovery Market Size by Type
6.2.1 Americas Virtual Screening for Drug Discovery Market Size by Type (2019-2024)
6.2.2 Americas Virtual Screening for Drug Discovery Market Size by Type (2025-2030)
6.2.3 Americas Virtual Screening for Drug Discovery Market Share by Type (2019-2030)
6.3 Americas Virtual Screening for Drug Discovery Market Size by Application
6.3.1 Americas Virtual Screening for Drug Discovery Market Size by Application (2019-2024)
6.3.2 Americas Virtual Screening for Drug Discovery Market Size by Application (2025-2030)
6.3.3 Americas Virtual Screening for Drug Discovery Market Share by Application (2019-2030)
6.4 Americas Virtual Screening for Drug Discovery Market Facts & Figures by Country (2019, 2023 & 2030)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA Virtual Screening for Drug Discovery Market Size YoY Growth 2019-2030
7.2 EMEA Virtual Screening for Drug Discovery Market Size by Type
7.2.1 EMEA Virtual Screening for Drug Discovery Market Size by Type (2019-2024)
7.2.2 EMEA Virtual Screening for Drug Discovery Market Size by Type (2025-2030)
7.2.3 EMEA Virtual Screening for Drug Discovery Market Share by Type (2019-2030)
7.3 EMEA Virtual Screening for Drug Discovery Market Size by Application
7.3.1 EMEA Virtual Screening for Drug Discovery Market Size by Application (2019-2024)
7.3.2 EMEA Virtual Screening for Drug Discovery Market Size by Application (2025-2030)
7.3.3 EMEA Virtual Screening for Drug Discovery Market Share by Application (2019-2030)
7.4 EMEA Virtual Screening for Drug Discovery Market Facts & Figures by Region (2019, 2023 & 2030)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China Virtual Screening for Drug Discovery Market Size by Type
8.1.1 China Virtual Screening for Drug Discovery Market Size by Type (2019-2024)
8.1.2 China Virtual Screening for Drug Discovery Market Size by Type (2025-2030)
8.1.3 China Virtual Screening for Drug Discovery Market Share by Type (2019-2030)
8.2 China Virtual Screening for Drug Discovery Market Size by Application
8.2.1 China Virtual Screening for Drug Discovery Market Size by Application (2019-2024)
8.2.2 China Virtual Screening for Drug Discovery Market Size by Application (2025-2030)
8.2.3 China Virtual Screening for Drug Discovery Market Share by Application (2019-2030)
9 APAC (excluding China)
9.1 APAC Virtual Screening for Drug Discovery Market Size YoY Growth 2019-2030
9.2 APAC Virtual Screening for Drug Discovery Market Size by Type
9.2.1 APAC Virtual Screening for Drug Discovery Market Size by Type (2019-2024)
9.2.2 APAC Virtual Screening for Drug Discovery Market Size by Type (2025-2030)
9.2.3 APAC Virtual Screening for Drug Discovery Market Share by Type (2019-2030)
9.3 APAC Virtual Screening for Drug Discovery Market Size by Application
9.3.1 APAC Virtual Screening for Drug Discovery Market Size by Application (2019-2024)
9.3.2 APAC Virtual Screening for Drug Discovery Market Size by Application (2025-2030)
9.3.3 APAC Virtual Screening for Drug Discovery Market Share by Application (2019-2030)
9.4 APAC Virtual Screening for Drug Discovery Market Facts & Figures by Region (2019, 2023 & 2030)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 ASEAN
9.4.5 India
10 Key Players Profiles
10.1 MedChemExpress
10.1.1 MedChemExpress Company Details
10.1.2 MedChemExpress Business Overview
10.1.3 MedChemExpress Virtual Screening for Drug Discovery Introduction
10.1.4 MedChemExpress Revenue in Virtual Screening for Drug Discovery Business (2019-2024)
10.1.5 MedChemExpress Recent Development
10.2 TargetMol
10.2.1 TargetMol Company Details
10.2.2 TargetMol Business Overview
10.2.3 TargetMol Virtual Screening for Drug Discovery Introduction
10.2.4 TargetMol Revenue in Virtual Screening for Drug Discovery Business (2019-2024)
10.2.5 TargetMol Recent Development
10.3 OpenEye Scientific
10.3.1 OpenEye Scientific Company Details
10.3.2 OpenEye Scientific Business Overview
10.3.3 OpenEye Scientific Virtual Screening for Drug Discovery Introduction
10.3.4 OpenEye Scientific Revenue in Virtual Screening for Drug Discovery Business (2019-2024)
10.3.5 OpenEye Scientific Recent Development
10.4 Eurofins Discovery
10.4.1 Eurofins Discovery Company Details
10.4.2 Eurofins Discovery Business Overview
10.4.3 Eurofins Discovery Virtual Screening for Drug Discovery Introduction
10.4.4 Eurofins Discovery Revenue in Virtual Screening for Drug Discovery Business (2019-2024)
10.4.5 Eurofins Discovery Recent Development
10.5 Sygnature Discovery
10.5.1 Sygnature Discovery Company Details
10.5.2 Sygnature Discovery Business Overview
10.5.3 Sygnature Discovery Virtual Screening for Drug Discovery Introduction
10.5.4 Sygnature Discovery Revenue in Virtual Screening for Drug Discovery Business (2019-2024)
10.5.5 Sygnature Discovery Recent Development
10.6 Jubilant Biosys
10.6.1 Jubilant Biosys Company Details
10.6.2 Jubilant Biosys Business Overview
10.6.3 Jubilant Biosys Virtual Screening for Drug Discovery Introduction
10.6.4 Jubilant Biosys Revenue in Virtual Screening for Drug Discovery Business (2019-2024)
10.6.5 Jubilant Biosys Recent Development
10.7 Schrödinger, Inc.
10.7.1 Schrödinger, Inc. Company Details
10.7.2 Schrödinger, Inc. Business Overview
10.7.3 Schrödinger, Inc. Virtual Screening for Drug Discovery Introduction
10.7.4 Schrödinger, Inc. Revenue in Virtual Screening for Drug Discovery Business (2019-2024)
10.7.5 Schrödinger, Inc. Recent Development
10.8 Cresset Group
10.8.1 Cresset Group Company Details
10.8.2 Cresset Group Business Overview
10.8.3 Cresset Group Virtual Screening for Drug Discovery Introduction
10.8.4 Cresset Group Revenue in Virtual Screening for Drug Discovery Business (2019-2024)
10.8.5 Cresset Group Recent Development
10.9 ComputaBio
10.9.1 ComputaBio Company Details
10.9.2 ComputaBio Business Overview
10.9.3 ComputaBio Virtual Screening for Drug Discovery Introduction
10.9.4 ComputaBio Revenue in Virtual Screening for Drug Discovery Business (2019-2024)
10.9.5 ComputaBio Recent Development
10.10 Profacgen
10.10.1 Profacgen Company Details
10.10.2 Profacgen Business Overview
10.10.3 Profacgen Virtual Screening for Drug Discovery Introduction
10.10.4 Profacgen Revenue in Virtual Screening for Drug Discovery Business (2019-2024)
10.10.5 Profacgen Recent Development
10.11 CD ComputaBio
10.11.1 CD ComputaBio Company Details
10.11.2 CD ComputaBio Business Overview
10.11.3 CD ComputaBio Virtual Screening for Drug Discovery Introduction
10.11.4 CD ComputaBio Revenue in Virtual Screening for Drug Discovery Business (2019-2024)
10.11.5 CD ComputaBio Recent Development
10.12 Creative Biolabs
10.12.1 Creative Biolabs Company Details
10.12.2 Creative Biolabs Business Overview
10.12.3 Creative Biolabs Virtual Screening for Drug Discovery Introduction
10.12.4 Creative Biolabs Revenue in Virtual Screening for Drug Discovery Business (2019-2024)
10.12.5 Creative Biolabs Recent Development
10.13 BOC Sciences
10.13.1 BOC Sciences Company Details
10.13.2 BOC Sciences Business Overview
10.13.3 BOC Sciences Virtual Screening for Drug Discovery Introduction
10.13.4 BOC Sciences Revenue in Virtual Screening for Drug Discovery Business (2019-2024)
10.13.5 BOC Sciences Recent Development
10.14 CKTTDB
10.14.1 CKTTDB Company Details
10.14.2 CKTTDB Business Overview
10.14.3 CKTTDB Virtual Screening for Drug Discovery Introduction
10.14.4 CKTTDB Revenue in Virtual Screening for Drug Discovery Business (2019-2024)
10.14.5 CKTTDB Recent Development
10.15 HitGen
10.15.1 HitGen Company Details
10.15.2 HitGen Business Overview
10.15.3 HitGen Virtual Screening for Drug Discovery Introduction
10.15.4 HitGen Revenue in Virtual Screening for Drug Discovery Business (2019-2024)
10.15.5 HitGen Recent Development
10.16 WuXi AppTec
10.16.1 WuXi AppTec Company Details
10.16.2 WuXi AppTec Business Overview
10.16.3 WuXi AppTec Virtual Screening for Drug Discovery Introduction
10.16.4 WuXi AppTec Revenue in Virtual Screening for Drug Discovery Business (2019-2024)
10.16.5 WuXi AppTec Recent Development
10.17 LeadBuilder
10.17.1 LeadBuilder Company Details
10.17.2 LeadBuilder Business Overview
10.17.3 LeadBuilder Virtual Screening for Drug Discovery Introduction
10.17.4 LeadBuilder Revenue in Virtual Screening for Drug Discovery Business (2019-2024)
10.17.5 LeadBuilder Recent Development
10.18 CSNpharm
10.18.1 CSNpharm Company Details
10.18.2 CSNpharm Business Overview
10.18.3 CSNpharm Virtual Screening for Drug Discovery Introduction
10.18.4 CSNpharm Revenue in Virtual Screening for Drug Discovery Business (2019-2024)
10.18.5 CSNpharm Recent Development
10.19 ChemNavigator
10.19.1 ChemNavigator Company Details
10.19.2 ChemNavigator Business Overview
10.19.3 ChemNavigator Virtual Screening for Drug Discovery Introduction
10.19.4 ChemNavigator Revenue in Virtual Screening for Drug Discovery Business (2019-2024)
10.19.5 ChemNavigator Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Virtual Screening for Drug Discovery Market Size, United States VS Global, CAGR (2019 VS 2023 VS 2030)
Table 2. Virtual Screening for Drug Discovery Market Trends
Table 3. Virtual Screening for Drug Discovery Market Drivers
Table 4. Virtual Screening for Drug Discovery Market Challenges
Table 5. Virtual Screening for Drug Discovery Market Restraints
Table 6. Global Virtual Screening for Drug Discovery Market Size Growth Rate (CAGR) by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 7. United States Virtual Screening for Drug Discovery Market Size by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 8. Global Virtual Screening for Drug Discovery Market Size Growth Rate (CAGR) by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 9. United States Virtual Screening for Drug Discovery Market Size by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 10. Global Key Companies of Virtual Screening for Drug Discovery, Ranked by Revenue (2023) & (US$ Million)
Table 11. Global Virtual Screening for Drug Discovery Revenue by Player, (US$ Million), 2019-2024
Table 12. Global Virtual Screening for Drug Discovery Revenue Share by Player, 2019-2024
Table 13. Global Virtual Screening for Drug Discovery Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Virtual Screening for Drug Discovery by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Virtual Screening for Drug Discovery as of 2023)
Table 15. Global Key Players of Virtual Screening for Drug Discovery, Headquarters and Area Served
Table 16. Global Key Players of Virtual Screening for Drug Discovery, Product and Application
Table 17. Global Key Players of Virtual Screening for Drug Discovery, Date of Enter into This Industry
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Key Players of Virtual Screening for Drug Discovery in United States, Ranked by Revenue (2023) & (US$ Million)
Table 20. United States Virtual Screening for Drug Discovery Revenue by Players, (US$ Million), 2022, 2023 & 2024
Table 21. United States Virtual Screening for Drug Discovery Revenue Share by Players, 2022, 2023 & 2024
Table 22. Global Virtual Screening for Drug Discovery Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 23. Global Virtual Screening for Drug Discovery Market Size by Region (2019-2024) & (US$ Million)
Table 24. Global Virtual Screening for Drug Discovery Market Size Forecast by Region (2025-2030) & (US$ Million)
Table 25. Americas Virtual Screening for Drug Discovery Market Size by Type (2019-2024) & (US$ Million)
Table 26. Americas Virtual Screening for Drug Discovery Market Size by Type (2025-2030) & (US$ Million)
Table 27. Americas Virtual Screening for Drug Discovery Market Size by Application (2019-2024) & (US$ Million)
Table 28. Americas Virtual Screening for Drug Discovery Market Size by Application (2025-2030) & (US$ Million)
Table 29. Americas Virtual Screening for Drug Discovery Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 30. Americas Virtual Screening for Drug Discovery Market Size by Country (2019-2024) & (US$ Million)
Table 31. Americas Virtual Screening for Drug Discovery Market Size by Country (2025-2030) & (US$ Million)
Table 32. EMEA Virtual Screening for Drug Discovery Market Size by Type (2019-2024) & (US$ Million)
Table 33. EMEA Virtual Screening for Drug Discovery Market Size by Type (2025-2030) & (US$ Million)
Table 34. EMEA Virtual Screening for Drug Discovery Market Size by Application (2019-2024) & (US$ Million)
Table 35. EMEA Virtual Screening for Drug Discovery Market Size by Application (2025-2030) & (US$ Million)
Table 36. EMEA Virtual Screening for Drug Discovery Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 37. EMEA Virtual Screening for Drug Discovery Market Size by Region (2019-2024) & (US$ Million)
Table 38. EMEA Virtual Screening for Drug Discovery Market Size by Region (2025-2030) & (US$ Million)
Table 39. China Virtual Screening for Drug Discovery Market Size by Type (2019-2024) & (US$ Million)
Table 40. China Virtual Screening for Drug Discovery Market Size by Type (2025-2030) & (US$ Million)
Table 41. China Virtual Screening for Drug Discovery Market Size by Application (2019-2024) & (US$ Million)
Table 42. China Virtual Screening for Drug Discovery Market Size by Application (2025-2030) & (US$ Million)
Table 43. APAC Virtual Screening for Drug Discovery Market Size by Type (2019-2024) & (US$ Million)
Table 44. APAC Virtual Screening for Drug Discovery Market Size by Type (2025-2030) & (US$ Million)
Table 45. APAC Virtual Screening for Drug Discovery Market Size by Application (2019-2024) & (US$ Million)
Table 46. APAC Virtual Screening for Drug Discovery Market Size by Application (2025-2030) & (US$ Million)
Table 47. APAC Virtual Screening for Drug Discovery Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 48. APAC Virtual Screening for Drug Discovery Market Size by Region (2025-2030) & (US$ Million)
Table 49. APAC Virtual Screening for Drug Discovery Market Size by Region (2025-2030) & (US$ Million)
Table 50. MedChemExpress Company Details
Table 51. MedChemExpress Business Overview
Table 52. MedChemExpress Virtual Screening for Drug Discovery Product
Table 53. MedChemExpress Revenue in Virtual Screening for Drug Discovery Business (2019-2024) & (US$ Million)
Table 54. MedChemExpress Recent Development
Table 55. TargetMol Company Details
Table 56. TargetMol Business Overview
Table 57. TargetMol Virtual Screening for Drug Discovery Product
Table 58. TargetMol Revenue in Virtual Screening for Drug Discovery Business (2019-2024) & (US$ Million)
Table 59. TargetMol Recent Development
Table 60. OpenEye Scientific Company Details
Table 61. OpenEye Scientific Business Overview
Table 62. OpenEye Scientific Virtual Screening for Drug Discovery Product
Table 63. OpenEye Scientific Revenue in Virtual Screening for Drug Discovery Business (2019-2024) & (US$ Million)
Table 64. OpenEye Scientific Recent Development
Table 65. Eurofins Discovery Company Details
Table 66. Eurofins Discovery Business Overview
Table 67. Eurofins Discovery Virtual Screening for Drug Discovery Product
Table 68. Eurofins Discovery Revenue in Virtual Screening for Drug Discovery Business (2019-2024) & (US$ Million)
Table 69. Eurofins Discovery Recent Development
Table 70. Sygnature Discovery Company Details
Table 71. Sygnature Discovery Business Overview
Table 72. Sygnature Discovery Virtual Screening for Drug Discovery Product
Table 73. Sygnature Discovery Revenue in Virtual Screening for Drug Discovery Business (2019-2024) & (US$ Million)
Table 74. Sygnature Discovery Recent Development
Table 75. Jubilant Biosys Company Details
Table 76. Jubilant Biosys Business Overview
Table 77. Jubilant Biosys Virtual Screening for Drug Discovery Product
Table 78. Jubilant Biosys Revenue in Virtual Screening for Drug Discovery Business (2019-2024) & (US$ Million)
Table 79. Jubilant Biosys Recent Development
Table 80. Schrödinger, Inc. Company Details
Table 81. Schrödinger, Inc. Business Overview
Table 82. Schrödinger, Inc. Virtual Screening for Drug Discovery Product
Table 83. Schrödinger, Inc. Revenue in Virtual Screening for Drug Discovery Business (2019-2024) & (US$ Million)
Table 84. Schrödinger, Inc. Recent Development
Table 85. Cresset Group Company Details
Table 86. Cresset Group Business Overview
Table 87. Cresset Group Virtual Screening for Drug Discovery Product
Table 88. Cresset Group Revenue in Virtual Screening for Drug Discovery Business (2019-2024) & (US$ Million)
Table 89. Cresset Group Recent Development
Table 90. ComputaBio Company Details
Table 91. ComputaBio Business Overview
Table 92. ComputaBio Virtual Screening for Drug Discovery Product
Table 93. ComputaBio Revenue in Virtual Screening for Drug Discovery Business (2019-2024) & (US$ Million)
Table 94. ComputaBio Recent Development
Table 95. Profacgen Company Details
Table 96. Profacgen Business Overview
Table 97. Profacgen Virtual Screening for Drug Discovery Product
Table 98. Profacgen Revenue in Virtual Screening for Drug Discovery Business (2019-2024) & (US$ Million)
Table 99. Profacgen Recent Development
Table 100. CD ComputaBio Company Details
Table 101. CD ComputaBio Business Overview
Table 102. CD ComputaBio Virtual Screening for Drug Discovery Product
Table 103. CD ComputaBio Revenue in Virtual Screening for Drug Discovery Business (2019-2024) & (US$ Million)
Table 104. CD ComputaBio Recent Development
Table 105. Creative Biolabs Company Details
Table 106. Creative Biolabs Business Overview
Table 107. Creative Biolabs Virtual Screening for Drug Discovery Product
Table 108. Creative Biolabs Revenue in Virtual Screening for Drug Discovery Business (2019-2024) & (US$ Million)
Table 109. Creative Biolabs Recent Development
Table 110. BOC Sciences Company Details
Table 111. BOC Sciences Business Overview
Table 112. BOC Sciences Virtual Screening for Drug Discovery Product
Table 113. BOC Sciences Revenue in Virtual Screening for Drug Discovery Business (2019-2024) & (US$ Million)
Table 114. BOC Sciences Recent Development
Table 115. CKTTDB Company Details
Table 116. CKTTDB Business Overview
Table 117. CKTTDB Virtual Screening for Drug Discovery Product
Table 118. CKTTDB Revenue in Virtual Screening for Drug Discovery Business (2019-2024) & (US$ Million)
Table 119. CKTTDB Recent Development
Table 120. HitGen Company Details
Table 121. HitGen Business Overview
Table 122. HitGen Virtual Screening for Drug Discovery Product
Table 123. HitGen Revenue in Virtual Screening for Drug Discovery Business (2019-2024) & (US$ Million)
Table 124. HitGen Recent Development
Table 125. WuXi AppTec Company Details
Table 126. WuXi AppTec Business Overview
Table 127. WuXi AppTec Virtual Screening for Drug Discovery Product
Table 128. WuXi AppTec Revenue in Virtual Screening for Drug Discovery Business (2019-2024) & (US$ Million)
Table 129. WuXi AppTec Recent Development
Table 130. LeadBuilder Company Details
Table 131. LeadBuilder Business Overview
Table 132. LeadBuilder Virtual Screening for Drug Discovery Product
Table 133. LeadBuilder Revenue in Virtual Screening for Drug Discovery Business (2019-2024) & (US$ Million)
Table 134. LeadBuilder Recent Development
Table 135. CSNpharm Company Details
Table 136. CSNpharm Business Overview
Table 137. CSNpharm Virtual Screening for Drug Discovery Product
Table 138. CSNpharm Revenue in Virtual Screening for Drug Discovery Business (2019-2024) & (US$ Million)
Table 139. CSNpharm Recent Development
Table 140. ChemNavigator Company Details
Table 141. ChemNavigator Business Overview
Table 142. ChemNavigator Virtual Screening for Drug Discovery Product
Table 143. ChemNavigator Revenue in Virtual Screening for Drug Discovery Business (2019-2024) & (US$ Million)
Table 144. ChemNavigator Recent Development
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Virtual Screening for Drug Discovery Product Picture
Figure 2. Global Virtual Screening for Drug Discovery Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Virtual Screening for Drug Discovery Market Size 2019-2030 (US$ Million)
Figure 4. United States Virtual Screening for Drug Discovery Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 5. United States Virtual Screening for Drug Discovery Market Size 2019-2030 (US$ Million)
Figure 6. United States Virtual Screening for Drug Discovery Market Share in Global 2019-2030
Figure 7. Virtual Screening for Drug Discovery Report Years Considered
Figure 8. Product Picture of Structure-based Virtual Screening (SBVS)
Figure 9. Product Picture of Ligand-based Virtual Screening (LBVS)
Figure 10. Product Picture of Hybrid Methods
Figure 11. Global Virtual Screening for Drug Discovery Market Share by Type in 2023 & 2030
Figure 12. Global Virtual Screening for Drug Discovery Market Size by Type (2019-2030) & (US$ Million)
Figure 13. Global Virtual Screening for Drug Discovery Market Share by Type (2019-2030)
Figure 14. United States Virtual Screening for Drug Discovery Market Share by Type in 2023 & 2030
Figure 15. United States Virtual Screening for Drug Discovery Market Size by Type (2019-2030) & (US$ Million)
Figure 16. United States Virtual Screening for Drug Discovery Market Share by Type (2019-2030)
Figure 17. Product Picture of Pharmaceutical Company
Figure 18. Product Picture of Universities and Research Institutions
Figure 19. Product Picture of Others
Figure 20. Global Virtual Screening for Drug Discovery Market Share by Application in 2023 & 2030
Figure 21. Global Virtual Screening for Drug Discovery Market Size by Application (2019-2030) & (US$ Million)
Figure 22. Global Virtual Screening for Drug Discovery Market Share by Application (2019-2030)
Figure 23. United States Virtual Screening for Drug Discovery Market Share by Application in 2023 & 2030
Figure 24. United States Virtual Screening for Drug Discovery Market Size by Application (2019-2030) & (US$ Million)
Figure 25. United States Virtual Screening for Drug Discovery Market Share by Application (2019-2030)
Figure 26. The Top 5 and 10 Largest Companies of Virtual Screening for Drug Discovery in the World: Market Share by Virtual Screening for Drug Discovery Revenue in 2023
Figure 27. Global Virtual Screening for Drug Discovery Market Size Market Share by Region: 2019 VS 2023 VS 2030
Figure 28. Global Virtual Screening for Drug Discovery Market Share by Region (2019-2030)
Figure 29. Americas Virtual Screening for Drug Discovery Market Size Growth Rate 2019-2030 (US$ Million)
Figure 30. Americas Virtual Screening for Drug Discovery Market Share by Type (2019-2030)
Figure 31. Americas Virtual Screening for Drug Discovery Market Share by Application (2019-2030)
Figure 32. United States Virtual Screening for Drug Discovery Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 33. Canada Virtual Screening for Drug Discovery Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 34. Mexico Virtual Screening for Drug Discovery Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 35. Brazil Virtual Screening for Drug Discovery Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 36. EMEA Virtual Screening for Drug Discovery Market Size Growth Rate 2019-2030 (US$ Million)
Figure 37. EMEA Virtual Screening for Drug Discovery Market Share by Type (2019-2030)
Figure 38. EMEA Virtual Screening for Drug Discovery Market Share by Application (2019-2030)
Figure 39. Europe Virtual Screening for Drug Discovery Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 40. Middle East Virtual Screening for Drug Discovery Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 41. Africa Virtual Screening for Drug Discovery Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 42. China Virtual Screening for Drug Discovery Market Size Growth Rate 2019-2030 (US$ Million)
Figure 43. China Virtual Screening for Drug Discovery Market Share by Type (2019-2030)
Figure 44. China Virtual Screening for Drug Discovery Market Share by Application (2019-2030)
Figure 45. APAC Virtual Screening for Drug Discovery Market Size Growth Rate 2019-2030 (US$ Million)
Figure 46. APAC Virtual Screening for Drug Discovery Market Share by Type (2019-2030)
Figure 47. APAC Virtual Screening for Drug Discovery Market Share by Application (2019-2030)
Figure 48. Japan Virtual Screening for Drug Discovery Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 49. South Korea Virtual Screening for Drug Discovery Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 50. China Taiwan Virtual Screening for Drug Discovery Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 51. ASEAN Virtual Screening for Drug Discovery Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 52. India Virtual Screening for Drug Discovery Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 53. MedChemExpress Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2019-2024)
Figure 54. TargetMol Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2019-2024)
Figure 55. OpenEye Scientific Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2019-2024)
Figure 56. Eurofins Discovery Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2019-2024)
Figure 57. Sygnature Discovery Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2019-2024)
Figure 58. Jubilant Biosys Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2019-2024)
Figure 59. Schrödinger, Inc. Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2019-2024)
Figure 60. Cresset Group Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2019-2024)
Figure 61. ComputaBio Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2019-2024)
Figure 62. Profacgen Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2019-2024)
Figure 63. CD ComputaBio Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2019-2024)
Figure 64. Creative Biolabs Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2019-2024)
Figure 65. BOC Sciences Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2019-2024)
Figure 66. CKTTDB Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2019-2024)
Figure 67. HitGen Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2019-2024)
Figure 68. WuXi AppTec Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2019-2024)
Figure 69. LeadBuilder Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2019-2024)
Figure 70. CSNpharm Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2019-2024)
Figure 71. ChemNavigator Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2019-2024)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Virtual Screening for Drug Discovery market?
The top companies in the global Virtual Screening for Drug Discovery market are MedChemExpress、TargetMol、OpenEye Scientific.
Related Reports
Global Virtual Screening for Drug Discovery Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Virtual Screening for Drug Discovery market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-31
Pages: 160
USD 4900.00
(Single User License)
Global Virtual Screening for Drug Discovery Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Virtual Screening for Drug Discovery market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-31
Pages: 105
USD 4250.00
(Single User License)
Virtual Screening for Drug Discovery - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Virtual Screening for Drug Discovery was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 139
USD 3950.00
(Single User License)
Global Virtual Screening for Drug Discovery Market Research Report 2026
The global Virtual Screening for Drug Discovery market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-15
Pages: 127
USD 2900.00
(Single User License)
Global Virtual Screening for Drug Discovery Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Virtual Screening for Drug Discovery market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 105
USD 4250.00
(Single User License)
Global Virtual Screening for Drug Discovery Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Virtual Screening for Drug Discovery market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-05
Pages: 156
USD 4900.00
(Single User License)
Virtual Screening for Drug Discovery- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Virtual Screening for Drug Discovery was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-11
Pages: 121
USD 3950.00
(Single User License)
Global Virtual Screening for Drug Discovery Market Research Report 2025
The global market for Virtual Screening for Drug Discovery was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-11
Pages: 99
USD 2900.00
(Single User License)
Global Virtual Screening for Drug Discovery Market Research Report 2024
Virtual screening (VS) is a computational technique used in drug discovery to search libraries of small molecules in order to identify those structures which are most likely to bind to a drug target, typically a protein receptor or enzyme.
Published Date: 2024-04-28
Pages: 95
USD 2900.00
(Single User License)
Virtual Screening for Drug Discovery- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Virtual screening (VS) is a computational technique used in drug discovery to search libraries of small molecules in order to identify those structures which are most likely to bind to a drug target, typically a protein receptor or enzyme.
Published Date: 2024-04-28
Pages: 138
USD 3950.00
(Single User License)
Global Virtual Screening for Drug Discovery Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Virtual Screening for Drug Discovery market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-31
Pages: 160
USD 4900.00 (Single User License)Global Virtual Screening for Drug Discovery Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Virtual Screening for Drug Discovery market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-31
Pages: 105
USD 4250.00 (Single User License)Virtual Screening for Drug Discovery - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Virtual Screening for Drug Discovery was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 139
USD 3950.00 (Single User License)Global Virtual Screening for Drug Discovery Market Research Report 2026
The global Virtual Screening for Drug Discovery market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-15
Pages: 127
USD 2900.00 (Single User License)Global Virtual Screening for Drug Discovery Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Virtual Screening for Drug Discovery market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 105
USD 4250.00 (Single User License)Global Virtual Screening for Drug Discovery Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Virtual Screening for Drug Discovery market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-05
Pages: 156
USD 4900.00 (Single User License)Virtual Screening for Drug Discovery- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Virtual Screening for Drug Discovery was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-11
Pages: 121
USD 3950.00 (Single User License)Global Virtual Screening for Drug Discovery Market Research Report 2025
The global market for Virtual Screening for Drug Discovery was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-11
Pages: 99
USD 2900.00 (Single User License)Global Virtual Screening for Drug Discovery Market Research Report 2024
Virtual screening (VS) is a computational technique used in drug discovery to search libraries of small molecules in order to identify those structures which are most likely to bind to a drug target, typically a protein receptor or enzyme.
Published: 2024-04-28
Pages: 95
USD 2900.00 (Single User License)Virtual Screening for Drug Discovery- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Virtual screening (VS) is a computational technique used in drug discovery to search libraries of small molecules in order to identify those structures which are most likely to bind to a drug target, typically a protein receptor or enzyme.
Published: 2024-04-28
Pages: 138
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4350.00
USD 6525.00
USD 8700.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now